Evidence map›Paper›PMID 40248701›Full record

ReviewFrontiers in immunology2025

Influence of cell bioenergetics on host-pathogen interaction in the lung.

Gaurav Kumar Lohia, Sebastián A Riquelme

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Revealing fitness and virulence determinants of hypervirulentFrontiers in cellular and infection microbiology · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gaurav Kumar LohiaDepartment of Pediatrics, Columbia University, New York, NY, United States.
Sebastián A RiquelmeDepartment of Pediatrics, Columbia University, New York, NY, United States.

Funding

Impact of nucleotide metabolism on bacterial clearanceR35GM146776 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Sebastian Alejandro Riquelme Colet · 2022 to 2026
$2.0M
Impact of Regulatory T Cells on Host Susceptibility to Pseudomonas Aeruginosa InfectionR21AI181780 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Sebastian Alejandro Riquelme Colet · 2025 to 2026
$445k
NIAID NIH HHS R21 AI181780NIGMS NIH HHS R35 GM146776
6 · The paper itself

Abstract

Pulmonary diseases, arising from infections caused by bacteria, fungi, and viruses, or stemming from underlying genetic factors are one of the leading causes of mortality in humans, accounting for millions of deaths every year. At the onset of pulmonary diseases, crucial roles are played by phagocytic immune cells, particularly tissue-resident macrophages, in regulating the immune response at the mucosal barrier. Recent strides have illuminated the pivotal role of host bioenergetics modulated by metabolites derived from both pathogens and hosts in influencing the pathophysiology of major organs. Their influence extends to processes such as the infiltration of immune cells, activation of macrophages, and the polarization phenomenon. Furthermore, host-derived metabolites, such as itaconate, contribute to the promotion of anti-inflammatory responses, thereby preventing immunopathology and facilitating the preservation of mucosal niches to thrive for the long-term. This review explores recent advancements in the field of immunometabolism, with a particular emphasis on the intricacies of disease progression in pulmonary infections caused by bacteria such as

Indexed as

Energy MetabolismHost-Pathogen InteractionsLungLung DiseasesAnimalsHumansMacrophagesbioenergeticsESKAPE bacteriafungal infectionhost-pathogen interactionimmunometabolismitaconateMACROPHAGE METABOLISMpneumonia (infectious disease)

Identifiers

PMID40248701
PMCPMC12003392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.